Applied DNA Sciences, Inc. (APDN) - NASDAQ
  • Sep. 11, 2015, 3:41 PM
    • Security solutions firm Applied DNA Sciences (APDN +9.4%) acquires privately-held Vandalia Research for $1.5M in cash. Vandalia's core technology, Triathlon DNA production technology, allows for the large-scale production of specific DNA sequences using polymerase chain reaction (PCR).
    • Triathlon will facilitate Applied's strategic intent to be able to DNA mark individual doses of drugs, a major initiative in the war against counterfeits.
    • CEO Dr. James Hayward says, "Expanding our manufacturing capacity through the acquisition of Vandalia's Triathlon PCR machines is opportune as we move toward converting pilot projects to commercial deployment, and creates, we believe, the world's largest manufacturing capacity of DNA in bulk using PCR."
    | Sep. 11, 2015, 3:41 PM | 3 Comments
Company Description
Applied DNA Sciences, Inc. provides botanical-DNA based security and authentication solutions, which protects products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Applied DNA Sciences was founded in 1983 and is... More
Sector: Healthcare
Industry: Biotechnology
Country: United States